A review of potential biomarkers for assessing physical and psychological trauma in paediatric burns

Abstract

Biological markers that evaluate physical healing as well as psychological impact of a burn are essential for effective treatment of paediatric burns. The objective of this review is to summarize the evidence supporting the use of biomarkers in children with burns. An extensive review of the literature was performed using PubMed. A total of 59 biomarkers were identified relating to burn presence, specifically relating to processes involved in inflammation, wound healing, growth and metabolism. In addition, biomarkers involved in the stress response cascade following a burn trauma were also identified. Although many biomarkers have been identified that are potentially associated with burn-related physical and psychological trauma, an understanding of burn biology is still lacking in children. We propose that future research in the field of children’s burns should be conducted using broad screening methods for identifying potential biomarkers, examine the biological interactions of different biomarkers, utilize child-appropriate biological fluids such as urine or saliva, and include a range of different severity burns. Through further research, the biological response to burn injury may be fully realized and clinically relevant diagnostic tests and treatment therapies utilizing these biomarkers could be developed, for the improvement of healing outcomes in paediatric burn patients.

Keywords

Paediatric burns / Biomarker / Inflammatory / Hypothalamic-pituitary-adrenal axis / Physical trauma / Psychological trauma

References

[1] Sharma RK, Parashar A. Special considerations in paediatric burn patients. Indian J Plast Surg 2010; 43: S43-50.

[2] Dodd AR, Nelson-Mooney K, Greenhalgh DG, Beckett LA, Li Y, Palmieri TL. The effect of hand burns on quality of life in children. J Burn Care Res 2010; 31: 414-22.

[3] Yan J, Hill WF, Rehou S, Pinto R, Shahrokhi S, Jeschke MG. Sepsis criteria versus clinical diagnosis of sepsis in burn patients: a validation of current sepsis scores. Surgery 2018; 164: 1241-5.

[4] Klein GL, Herndon DN, Le PT, Andersen CR, Benjamin D, Rosen CJ. The effect of burn on serum concentrations of sclerostin and FGF23. Burns 2015; 41: 1532-5.

[5] Lucas VS.Psychological stress and wound healing in humans: what we know. Wounds 2011; 23: 76-83.

[6] Walburn J, Vedhara K, Hankins M, Rixon L, Weinman J. Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res 2009; 67: 253-71.

[7] Brown NJ, Kimble RM, Rodger S, Ware RS, McWhinney BC, Ungerer JP, et al. Biological markers of stress in pediatric acute burn injury. Burns 2014; 40: 887-95.

[8] Kenardy JA, Spence SH, Macleod AC. Screening for post-traumatic stress disorder in children after accidental injury. Pediatrics 2006; 118: 1002-9.

[9] Van Loey NE, Hofland HWC, Vlig M, Vandermeulen E, Rose T, Beelen RHJ, et al. Associations between traumatic stress symptoms, pain and bio-active components in burn wounds. Psychoneuroendocrinology 2018; 96: 1-5.

[10] Gee Kee E, Kimble RM, Cuttle L, Stockton K. Comparison of three different dressings for partial thickness burns in children: study protocol for a randomised controlled trial. Trials 2013; 14: 403.

[11] Maskell J, Newcombe P, Martin G, Kimble R. Psychosocial functioning differences in pediatric burn survivors compared with healthy norms. J Burn Care Res 2013; 34: 465-76.

[12] Robinson H, Norton S, Jarrett P, Broadbent E. The effects of psychological interventions on wound healing: a systematic review of randomized trials. Br J Health Psychol 2017; 22: 805-35.

[13] De Young AC, Hendrikz J, Kenardy JA, Cobham VE, Kimble RM. Prospective evaluation of parent distress following pediatric burns and identification of risk factors for young child and parent posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2014; 24: 9-17.

[14] De Young AC, Kenardy JA, Cobham VE, Kimble R. Prevalence, comorbidity and course of trauma reactions in young burn-injured children. J Child Psychol Psychiatry 2012; 53: 56-63.

[15] World Health Organization, International Programme on Chemical Safety.Biomarkers and risk assessment: concepts and principles / published under the joint sponsorship of the United Nations environment Programme, the International Labour Organisation, and the World Health Organization. Geneva: World Health Organization, 1993.

[16] Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS 2010; 5: 463-6.

[17] Kundes MF, Kement M. Value of procalcitonin levels as a predictive biomarker for sepsis in pediatric patients with burn injuries. Niger J Clin Pract 2019; 22: 881-4.

[18] Rosanova MT, Tramonti N, Taicz M, Martiren S, Basilico H, Signorelli C, et al. Assessment of C-reactive protein and procalcitonin levels to predict infection and mortality in burn children. Arch Argent Pediatr 2015; 113: 36-41.

[19] Finnerty CC, Herndon DN, Chinkes DL, Jeschke MG. Serum cytokine differences in severely burned children with and without sepsis. Shock (Augusta, Ga) 2007; 27: 4-9.

[20] Abdel-Hafez NM, Saleh Hassan Y, El-Metwally TH. A study on biomarkers, cytokines, and growth factors in children with burn injuries. Ann Burns Fire Disasters 2007; 20: 89-100.

[21] Rorison P, Thomlinson A, Hassan Z, Roberts SA, Ferguson MW, Shah M. Longitudinal changes in plasma transforming growth factor beta-1 and post-burn scarring in children. Burns 2010; 36: 89-96.

[22] Sedowofia K, Barclay C, Quaba A, Smith A, Stephen R, Thomson M, et al. The systemic stress response to thermal injury in children. Clin Endocrinol (Oxf) 1998; 49: 335-41.

[23] Norbury WB, Herndon DN, Branski LK, Chinkes DL, Jeschke MG. Urinary cortisol and catecholamine excretion after burn injury in children. J Clin Endocrinol Metab 2008; 93: 1270-5.

[24] Kulp GA, Herndon DN, Lee JO, Suman OE, Jeschke MG. Extent and magnitude of catecholamine surge in pediatric burned patients. Shock (Augusta, Ga) 2010; 33: 369-74.

[25] Tanzer C, Sampson DL, Broadbent JA, Cuttle L, Kempf M, Kimble RM, et al. Evaluation of haemoglobin in blister fluid as an indicator of paediatric burn wound depth. Burns 2015; 41: 1114-21.

[26] Zang T, Broszczak DA, Cuttle L, Broadbent JA, Tanzer C, Parker TJ. The blister fluid proteome of paediatric burns. J Proteomics 2016; 146: 122-32.

[27] Smolle C, Cambiaso-Daniel J, Forbes AA, Wurzer P, Hundeshagen G, Branski LK, et al. Recent trends in burn epidemiology worldwide: a systematic review. Burns 2017; 43: 249-57.

[28] Lanziotti VS, Póvoa P, Soares M, Silva JRLE, Barbosa AP, Salluh JIF. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva 2016; 28: 472-82.

[29] Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther 2011; 9: 71-9.

[30] Zang T, Broszczak DA, Broadbent JA, Cuttle L, Lu H, Parker TJ. The biochemistry of blister fluid from pediatric burn injuries: proteomics and metabolomics aspects. Expert Rev Proteomics 2016; 13: 35-53.

[31] Feghali-Bostwick C, Wright TM. Cytokines acute and chronic inflammation. Front Biosci 1997; 2: d12-26.

[32] Gulhar R, Jialal I. Physiology, Acute Phase Reactants. Treasure Island, FL: StatPearls Publishing, 2020.

[33] Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med 2019; 25: 1822-32.

[34] Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000 2015; 69: 142-59.

[35] McGeachy MJ, Cua DJ, Gaffen SLJI. The IL-17 family of cytokines in health and disease. Immunity 2019; 50: 892-906.

[36] Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, et al. Cytokine expression profile over time in severely burned pediatric patients. Shock (Augusta, Ga) 2006; 26: 13-9.

[37] Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, et al. Pathophysiologic response to severe burn injury. Ann Surg 2008; 248: 387-401.

[38] Jeschke MG, Gauglitz GG, Kulp GA, Finnerty CC, Williams FN, Kraft R, et al. Long-term persistence of the pathophysiologic response to severe burn injury. PLoS One 2011; 6: e21245.

[39] Essayan DM, Fox CC, Levi-Schaffer F, Alam R, Rosenwasser LJ. Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 1998; 102: 344-50.

[40] Jeschke MG, Barrow RE, Herndon DN. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 2004; 139: 641-7.

[41] Klein GL, Herndon DN, Goodman WG, Langman CB, Phillips WA, Dickson IR, et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone 1995; 17: 455-60.

[42] Silva LB, Neto APDS, Maia SMAS, Guimarães CDS, Quidute IL, Carvalho ADAT, et al. The role of TNF-α as a proinflammatory cytokine in pathological processes. Open Dent J 2019; 13: 332-8.

[43] Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ, 3rd, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009; 94: 1656-64.

[44] Lasseter HC, Provost AC, Chaby LE, Daskalakis NP, Haas M, Jeromin A. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: platform performance in post-traumatic stress disorder and Parkinson’s disease. Cytokine X 2020; 2: 100027.

[45] Jeschke MG, Finnerty CC, Herndon DN, Song J, Boehning D, Tompkins RG, et al. Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response. Ann Surg 2012; 255: 370-8.

[46] Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8: S3.

[47] Belmonte JA, Ibanez L, Ras MR, Aulesa C, Vinzo J, Iglesias J, et al. Iron metabolism in burned children. Eur J Pediatr 1999; 158: 556-9.

[48] Jeschke MG, Norbury WB, Finnerty CC, Mlcak RP, Kulp GA, Branski LK, et al. Age differences in inflammatory and hypermetabolic postburn responses. Pediatrics 2008; 121: 497-507.

[49] Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018; 9: 754.

[50] Kraft R, Herndon DN, Finnerty CC, Cox RA, Song J, Jeschke MG. Predictive value of IL-8 for sepsis and severe infections after burn injury: a clinical study. Shock (Augusta, Ga) 2015; 43: 222-7.

[51] Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 1999; 20: 954-9.

[52] Guilmeau S, Ducroc R, Bado A. Chapter 169-Leptin. In: Kastin AJ (ed). Handbook of Biologically Active Peptides, 2nd edn. Boston: Academic Press, 2013, 1251-6.

[53] Iikuni N, Lam QLK, Lu L, Matarese G, La Cava A. Leptin and inflammation. Curr Immunol Rev 2008; 4: 70-9.

[54] Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 2010; 50: 1-14.

[55] Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011; 127: 701-21.e1-70.

[56] Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 2009; 8: 40-52.

[57] Koutroulis I, Loscalzo SM, Kratimenos P, Singh S, Weiner E, Syriopoulou V, et al. Clinical applications of procalcitonin in pediatrics: an advanced biomarker for inflammation and infection-can it also be used in trauma? Int Sch Res Notices 2014; 2014: 286493.

[58] Neely AN, Fowler LA, Kagan RJ, Warden GD. Procalcitonin in pediatric burn patients: an early indicator of sepsis? J Burn Care Rehabil 2004; 25: 76-80.

[59] Shores DR, Everett AD. Children as biomarker orphans: progress in the field of pediatric biomarkers. J Pediatr 2018; 193: 14-20.e31.

[60] Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000; 49: S57-61.

[61] Matwiyoff GN, Prahl JD, Miller RJ, Carmichael JJ, Amundson DE, Seda G, et al. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res 2012; 61: 401-9.

[62] Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313-26.

[63] Bishara N.The use of biomarkers for detection of early-and late-onset neonatal sepsis. In: Ohls RK, Maheshwari A (eds). Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies, 2nd edn. Philadelphia: W.B. Saunders, 2012, 303-15.

[64] Petzelbauer P, Watson CA, Pfau SE, Pober JSIL. 8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995; 7: 267-72.

[65] Kraft R, Kulp GA, Herndon DN, Emdad F, Williams FN, Hawkins HK, et al. Is there a difference in clinical outcomes, inflammation, and hypermetabolism between scald and flame burn? Pediatr Crit Care Med 2011; 12: e275-81.

[66] Wu J, Xie A, Chen W. Cytokine regulation of immune tolerance. Burns & Trauma 2014; 2: 11-7.

[67] Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180: 5771.

[68] Jeschke MG, Mlcak RP, Finnerty CC, Norbury WB, Przkora R, Kulp GA, et al. Gender differences in pediatric burn patients: does it make a difference? Ann Surg 2008; 248: 126-36.

[69] de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998; 102: 165-9.

[70] Banchereau J, Pascual V, O’Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012; 13: 925-31.

[71] Risteli J, Niemi S, Kauppila S, Melkko J, Risteli L. Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand 1995; 66: 183-8.

[72] Henriksen K, Karsdal MA. Type I collagen. In: Karsdal MA (ed). Biochemistry of Collagens, Laminins and Elastin, 2nd edn. Cambridge, Massachusetts, United States: Academic Press, 2019, 1-12.

[73] Hart SM, Eastell R. Biochemical markers of bone turnover. Curr Opin Nephrol Hypertens 1999; 8: 421-7.

[74] Klein GL, Bi LX, Sherrard DJ, Beavan SR, Ireland D, Compston JE, et al. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 2004; 15: 468-74.

[75] Sand JMB, Genovese F, Gudmann NS, Karsdal MA. Type IV collagen. In: Karsdal MA (ed). Biochemistry of Collagens, Laminins and Elastin, 2nd edn. Cambridge, Massachusetts, United States: Academic Press, 2019, 37-49.

[76] Weremijewicz A, Matuszczak E, Sankiewicz A, Tylicka M, Komarowska M, Tokarzewicz A, et al. Matrix metalloproteinase-2 and its correlation with basal membrane components laminin-5 and collagen type IV in paediatric burn patients measured with surface Plasmon resonance imaging (SPRI) biosensors. Burns 2018; 44: 931-40.

[77] Schneider H, Mühle C, Pacho F.Biological function of laminin-5 and pathogenic impact of its deficiency. Eur J Cell Biol 2007; 86: 701-17.

[78] Loffek S, Schilling O, Franzke CW. Series "matrix metalloproteinases in lung health and disease": biological role of matrix metalloproteinases: a critical balance. Eur Respir J 2011; 38: 191-208.

[79] Xue M, Jackson CJ. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care 2015; 4: 119-36.

[80] Dasu MR, Spies M, Barrow RE, Herndon DN. Matrix metalloproteinases and their tissue inhibitors in severely burned children. Wound Repair Regen 2003; 11: 177-80.

[81] Tanaka K. The proteasome: overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85: 12-36.

[82] Matuszczak E, Tylicka M, Debek W, Hermanowicz A, Ostrowska H. Correlation between circulating proteasome activity, total protein and C-reactive protein levels following burn in children. Burns 2014; 40: 842-7.

[83] Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 588-610.

[84] Sherbet GV. The epidermal growth factor (EGF) family. In: Sherbet GV (ed). Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy. London: Elsevier, 2011, 173-98.

[85] Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009; 9: 447-53.

[86] Lifshitz V, Frenkel D. TGF-β. In: Kastin AJ (ed). Handbook of Biologically Active Peptides, 2nd edn. Boston: Academic Press, 2013, 1647-53.

[87] Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 2007; 4: e234.

[88] Tan J, Wu J. Current progress in understanding the molecular pathogenesis of burn scar contracture. Burns & Trauma 2017; 5: 14.

[89] Yun Y-R, Won JE, Jeon E, Lee S, Kang W, Jo H, et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010; 2010: 218142.

[90] Akita S, Akino K, Imaizumi T, Tanaka K, Anraku K, Yano H, et al. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor. J Burn Care Res 2006; 27: 333-8.

[91] Hayashida K, Fujioka M, Morooka S, Saijo H, Akita S. Effectiveness of basic fibroblast growth factor for pediatric hand burns. J Tissue Viability 2016; 25: 220-4.

[92] Prelack K, Dwyer J, Dallal GE, Rand WM, Yu YM, Kehayias JJ, et al. Growth deceleration and restoration after serious burn injury. J Burn Care Res 2007; 28: 262-8.

[93] Frohman LA.Growth hormone. In: Squire LR (ed). Encyclopedia of Neuroscience. Oxford: Academic Press, 2009, 993-8.

[94] Mahan JD, Ayoob R. Growth hormone. In: Singh AK, Williams GH (eds). Textbook of Nephro-Endocrinology, 2nd edn. Cambridge, Massachusetts, United States: Academic Press, 2018, 259-75.

[95] Fleming RY, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992; 32: 698-702 discussion-3.

[96] Morris CJ, Aeschbach D, Scheer FAJL. Circadian system, sleep and endocrinology. Mol Cell Endocrinol 2012; 349: 91-104.

[97] Meltzer LJ, Davis KF, Mindell JA. Patient and parent sleep in a children’s hospital. Pediatr Nurs 2012; 38: 64-71; quiz 2.

[98] Clemmons DR, Snyder P, Martin K. Physiology of insulin-like growth factor I, Netherlands: Wolters Kluwer. 2014 [updated 22/10/2019]. Available from: https://www.uptodate.com/contents/physiology-of-insulin-like-growth-factor-1.

[99] Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 2012; 41: 425-43.

[100] Jeschke MG, Mlcak RP, Finnerty CC, Norbury WB, Gauglitz GG, Kulp GA, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care 2007; 11: R90.

[101] Cooke DW, Divall SA, Radovick S. Normal and aberrant growth in children. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds). Williams Textbook of Endocrinology, 13th edn. Philadelphia: Elsevier, 2016, 964-1073.

[102] Rutan RL, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg 1990; 125: 392-5.

[103] Gottschlich MM, Jenkins ME, Mayes T, Khoury J, Kagan RJ, Warden GD. The 2002 clinical research award. An evaluation of the safety of early vs delayed enteral support and effects on clinical, nutritional, and endocrine outcomes after severe burns. J Burn Care Rehabil 2002; 23: 401-15.

[104] Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000; 278: E759-68.

[105] Fram RY, Cree MG, Wolfe RR, Barr D, Herndon DN. Impaired glucose tolerance in pediatric burn patients at discharge from the acute hospital stay. J Burn Care Res 2010; 31: 728-33.

[106] Kraft R, Herndon DN, Finnerty CC, Hiyama Y, Jeschke MG. Association of postburn fatty acids and triglycerides with clinical outcome in severely burned children. J Clin Endocrinol Metab 2013; 98: 314-21.

[107] Jensen MD, Martin ML, Cryer PE, Roust LR. Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 1994; 266: E914-20.

[108] Furman BL.Thyroxine. In: Reference Module in Biomedical Sciences. Netherlands: Elsevier; 2017.

[109] Jeschke MG, Przkora R, Suman OE, Finnerty CC, Mlcak RP, Pereira CT, et al. Sex differences in the long-term outcome after a severe thermal injury. Shock (Augusta, Ga) 2007; 27: 461-5.

[110] Abdalla SM, Bianco AC. Defending plasma T3 is a biological priority. Clin Endocrinol (Oxf) 2014; 81: 633-41.

[111] Berry R, Gillen P. Metabolic response to stress.In: Marshall WJ, Lapsley M, Day AP, Ayling RM (eds). Clinical Biochemistry: Metabolic and Clinical Aspects, 3rd edn. London: Churchill Livingstone, 2014, 403-11.

[112] Pupim LB, Martin CJ, Ikizler TA. Assessment of protein and energy nutritional status. In: Kopple JD, Massry SG, Kalantar-Zadeh K (eds). Nutritional Management of Renal Disease. Cambridge, Massachusetts, United States: Academic Press, 2013, 137-58.

[113] Jeschke MG, Lopez ON, Finnerty CC. The hepatic response to thermal injury. In: Herndon DN (ed). Total Burn Care, 5th edn. Netherlands: Elsevier, 2018, 259-67.e3.

[114] Barbosa S, Taboada P, Mosquera V. Fibrillation and polymorphism of human serum albumin. In: Uversky VN, Lyubchenko YL (eds). Bio-nanoimaging. Boston: Academic Press, 2014, 345-62.

[115] Palmieri TL, Levine S, Schonfeld-Warden N, O’Mara MS, Greenhalgh DG. Hypothalamic-pituitary-adrenal axis response to sustained stress after major burn injury in children. J Burn Care Res 2006; 27: 742-8.

[116] Harrison HH, Gordon ED, Nichols WC, Benson MD. Biochemical and clinical characterization of prealbumin^CHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis. Am J Med Genet 1991; 39: 442-52.

[117] Houston-Bolze MS, Downing MT, Sayed AM, Meserve LA. Gender differences in the responses of serum insulin-like growth factor-1 and transthyretin (prealbumin) to trauma. Crit Care Med 1996; 24: 1982-7.

[118] MC-M C.Structure and function of transferrin. Biochem Education 1984; 12: 146-54.

[119] Goodman DS.Plasma retinol-binding protein. Ann N Y Acad Sci. 1980; 348: 378-90.

[120] Zabetian-Targhi F, Mahmoudi MJ, Rezaei N, Mahmoudi M. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Adv Nutrition 2015; 6: 748-62.

[121] Kraft R, Herndon DN, Kulp GA, Mecott GA, Trentzsch H, Jeschke MG. Retinol binding protein: marker for insulin resistance and inflammation postburn? JPEN J Parenter Enteral Nutr 2011; 35: 695-703.

[122] Lofrese JJ, Basit H, Lappin SL. Physiology, Parathyroid. Treasure Island, FL: StatPearls, 2020.

[123] Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone 2016; 82: 42-9.

[124] Prelack K, Yu YM, Sheridan RL. Nutrition and metabolism in the rehabilitative phase of recovery in burn children: a review of clinical and research findings in a speciality pediatric burn hospital. Burns & Trauma 2015; 3: 7.

[125] Figueroa DM, Gordon EM, Yao X, Levine SJ. Apolipoproteins as context-dependent regulators of lung inflammation. In: Johnston RA, Suratt BT (eds). Mechanisms and Manifestations of Obesity in Lung Disease. Cambridge, Massachusetts, United States: Academic Press, 2019, 301-26.

[126] Mangaraj M, Nanda R, Panda S. Apolipoprotein A-I: a molecule of diverse function. Indian J Clin Biochem 2016; 31: 253-9.

[127] Fogelstrand P, Borén J. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis 2012; 22: 1-7.

[128] De Sousa A. Psychological aspects of paediatric burns (a clinical review). Ann Burns Fire Disasters 2010; 23: 155-9.

[129] Carr CP, Martins CMS, Stingel AM, Lemgruber VB, Juruena MF. The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes. J Nerv Ment Dis 2013; 201: 1007-20.

[130] Goodhew F, Van Hooff M, Sparnon A, Roberts R, Baur J, Saccone EJ, et al. Psychiatric outcomes amongst adult survivors of childhood burns. Burns 2014; 40: 1079-88.

[131] Stoddard FJ, Jr, Sorrentino E, Drake JE, Murphy JM, Kim AJ, Romo S, et al. Posttraumatic stress disorder diagnosis in young children with burns. J Burn Care Res 2017; 38: e343-51.

[132] Murison R.The neurobiology of stress. In: al’Absi M, Flaten MA (eds). Neuroscience of Pain, Stress, and Emotion. San Diego: Academic Press, 2016, 29-49.

[133] Godoy LD, Rossignoli MT, Delfino-Pereira P, Garcia-Cairasco N, de Lima Umeoka EH. A comprehensive overview on stress neurobiology: basic concepts and clinical implications. Front Behav Neurosci. 2018; 12: 127.

[134] Jeschke MG, Williams FN, Finnerty CC, Rodriguez NA, Kulp GA, Ferrando A, et al. The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes. PLoS One 2012; 7: e35465.

[135] Smith A, Barclay C, Quaba A, Sedowofia K, Stephen R, Thompson M, et al. The bigger the burn, the greater the stress. Burns 1997; 23: 291-4.

[136] Nater UM, La Marca R, Florin L, Moses A, Langhans W, Koller MM, et al. Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 2006; 31: 49-58.

[137] Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem 2011; 57: 675-87.

[138] Topkas E, Keith P, Dimeski G, Cooper-White J, Punyadeera C. Evaluation of saliva collection devices for the analysis of proteins. Clin Chim Acta 2012; 413: 1066-70.

[139] Morris MC, Hellman N, Abelson JL, Rao U. Cortisol, heart rate, and blood pressure as early markers of PTSD risk: a systematic review and meta-analysis. Clin Psychol Rev 2016; 49: 79-91.

[140] Levine A, Zagoory-Sharon O, Feldman R, Lewis JG, Weller A.Measuring cortisol in human psychobiological studies. Physiol Behav 2007; 90: 43-53.

[141] Steptoe A, Serwinski B. Cortisol awakening response. In: Fink G (ed). Stress: Concepts, Cognition, Emotion, and Behavior. San Diego: Academic Press, 2016, 277-83.

[142] Glover DA, Poland RE. Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology 2002; 27: 805-19.

[143] Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm 2013; 2013: 434010.

[144] Sosothikul D, Seksarn P, Lusher JM. Pediatric REFERENCE values for molecular markers in hemostasis. J Pediatr Hematol Oncol 2007; 29: 19-22.

[145] Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51: 540-4.

[146] Garcia DI, Cina RA, Corrigan C, Howard R, Lesher AP. 67 inter-hospital variation of inpatient versus outpatient pediatric burn treatment after emergency department evaluation. J Burn Care Res 2019; 40: S46.

[147] Duff AJA. Incorporating psychological approaches into routine paediatric venepuncture. Arch Dis Child 2003; 88: 931.

[148] Pandit P, Cooper-White J, Punyadeera C. High-yield RNA-extraction method for saliva. Clin Chem 2013; 59: 1118-22.

[149] Bel’skaya L, Sarf E, Kosenok V. Age and gender characteristics of the biochemical composition of saliva: correlations with the composition of blood plasma. J Oral Biol Craniofacial Res 2020; 10: 59-65.

[150] Finnerty CC, Ju H, Spratt H, Victor S, Jeschke MG, Hegde S, et al. Proteomics improves the prediction of burns mortality: results from regression spline modeling. Clin Transl Sci 2012; 5: 243-9.